| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.043 | 0.8 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |